Granahan Investment Management, LLC Abiomed Inc Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $2.7 Million - $3.6 Million	-10,260 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $798,288 - $991,522	-2,792 Reduced 21.39%	10,260 $3.27 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $3.29 Million - $4.23 Million	13,052 New	13,052 $4.23 Million
Q3 2020 Nov 12, 2020	SELL	$255.22 - $317.0 $970,346 - $1.21 Million	-3,802 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$141.4 - $257.09 $2.52 Million - $4.59 Million	-17,836 Reduced 82.43%	3,802 $919,000
Q1 2020 May 12, 2020	BUY	$130.51 - $196.01 $1.69 Million - $2.53 Million	12,911 Added 147.94%	21,638 $3.14 Million
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $59,900 - $84,051	-376 Reduced 4.13%	8,727 $1.49 Million
Q3 2019 Nov 15, 2019	SELL	$175.89 - $279.23 $1.95 Million - $3.1 Million	-11,097 Reduced 54.94%	9,103 $1.62 Million
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $150,325 - $170,679	-599 Reduced 2.88%	20,200 $5.26 Million
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $3.69 Million - $4.83 Million	13,334 Added 178.62%	20,799 $5.94 Million
Q4 2018 Feb 13, 2019	BUY	$281.08 - $444.25 $2.1 Million - $3.32 Million	7,465 New	7,465 $2.43 Million
Q2 2018 Aug 15, 2018	SELL	$278.07 - $446.21 $3.42 Million - $5.5 Million	-12,317 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$192.49 - $295.85 $13.9 Million - $21.4 Million	-72,245 Reduced 85.43%	12,317 $3.58 Million
Q4 2017 Feb 12, 2018	SELL	$168.78 - $199.74 $8.16 Million - $9.66 Million	-48,373 Reduced 36.39%	84,562 $15.8 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $19.3 Million - $22.4 Million	132,935	132,935 $22.4 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account